Outsourcing in Clinical Trials Nordics (OCT)

Direct-to-Patient shipment: Time to Stop and Think


Eric Schnitzer presents how Direct-to-Patient shipments were managed during COVID, the benefits and limitations of current solutions, and what the future of DtP should look like.

October 26, 2021


Eric Schnitzer image

Eric Schnitzer

Product Director, Calyx

Eric is a Product Director at Calyx with over 15 years of experience in eClinical technologies for clinical trials as well as for other healthcare products. He has a background working with various IRT solutions and with clinical supply groups from many Pharmaceutical and Biotech companies.

Stay Updated

Never miss a beat. Sign up to receive emails covering industry news and useful content to help you advance clinical development.

  • This field is for validation purposes and should be left unchanged.